In the case Association for Molecular Pathology v.Myriad Genetics,Inc.(2013),the U.S.Supreme Court held that under U.S.Patent Laws,isolated DNA is:
A) not eligible for patent protection because it is naturally occurring.
B) eligible for patent protection because it is human-made.
C) eligible for patent protection because it is naturally occurring.
D) not eligible for patent protection because it is human-made.

Question

Quizplus · Accepted Answer

The U.S. Supreme Court held that isolated DNA is not eligible for patent protection because it is a product of nature and not human-made. The Court ruled that simply isolating a naturally occurring DNA sequence does not make it patentable subject matter. However, complementary DNA (cDNA) that is synthesized from mRNA does qualify for patent protection because it is not naturally occurring.

In the Case Association for Molecular Pathology V